Wortham Laboratories welcomes you to SeraSeal with this overview of the product, its purpose, its marketplace and its performance. 

SeraSeal is the world’s first primary hemostatic agent, poised to cut time in surgery, reduce medical cost, lower need for post-op pain management and save lives by stopping bleeding.

SeraSeal belongs in every surgical theater, alongside every first responder and in every situation where bleeds are possible and their control would preserve tissue and lives.

SERASEAL_2022.mp4 from VIDEO CENTER on Vimeo.

SeraSeal:

2022 Introduction